Clinical Trial Update: The Predictive Role of Preoperative Pentraxin-3 (PTX3) in Metabolic and Inflammatory Outcomes After Roux-en-Y Gastric Bypass

View source ↗

Summary

A completed clinical trial evaluates whether preoperative PTX3 levels can predict metabolic and inflammatory outcomes after Roux-en-Y gastric bypass.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Insulin Resistance
• Metabolic Syndrome
• Obesity

Snippet

Sponsor: Istanbul University | Conditions: Obesity, Metabolic Syndrome | Status: COMPLETED